Stryker vs. Zimmer Biomet vs. Johnson and Johnson: How they compare in Q1 2024

Stryker, Johnson & Johnson and Zimmer Biomet posted their first-quarter financial results for 2024 and data on their orthopedic sales.

Advertisement

Here is how they compare:

Stryker

Total sales: $5.2 billion (+9.7%)

Orthopedics: $2.2 billion (+7.5%)

Hips: $393 million (+5.1%)

Knees: $588 million (+4%)

Spine: $300 million (+5.5%)

Zimmer Biomet

Total sales: $1.9 billion (+3.2%)

Hips: $491.2 million (+0.3%)

Knees: $788.1 million (+3.2%)

Sports medicine, extremities, trauma, craniomaxillofacial and thoracic: $452.6 million (+4.4%)

Johnson & Johnson

Total sales: $21.4 billion (+2.3%)

Orthopedic: $2.3 billion (+4.3%)

Spine, sports and other: $752 million (+3.2%)

Hips: $422 million (+8.1%)

Knees: $401 million (+9%)

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.